12.74% of Atossa Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atossa Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2024	GSA Capital Partners LLP	449,082	$0.40M	0.0%	+29.3%	0.358%
2/13/2024	Northern Trust Corp	227,922	$0.20M	0.0%	+6.2%	0.182%
11/15/2023	GSA Capital Partners LLP	347,392	$0.26M	0.0%	+14.8%	0.276%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	133,591	$98K	0.0%	N/A	0.106%
11/9/2023	UBS Group AG	33,359	$25K	0.0%	N/A	0.027%
8/15/2023	XTX Topco Ltd	39,383	$50K	0.0%	N/A	0.031%
8/14/2023	Two Sigma Securities LLC	25,178	$32K	0.0%	N/A	0.020%
8/14/2023	State Street Corp	436,271	$0.55M	0.0%	-9.3%	0.345%
8/11/2023	Renaissance Technologies LLC	1,074,070	$1.35M	0.0%	+14.7%	0.848%
8/11/2023	BlackRock Inc.	2,898,466	$3.65M	0.0%	-9.6%	2.289%
8/11/2023	Geode Capital Management LLC	1,112,612	$1.40M	0.0%	-8.1%	0.879%
8/3/2023	Bank of New York Mellon Corp	112,656	$0.14M	0.0%	-25.5%	0.089%
7/31/2023	LPL Financial LLC	46,992	$59K	0.0%	N/A	0.037%
7/27/2023	Virtu Financial LLC	86,813	$0.11M	0.0%	N/A	0.069%
7/7/2023	LVM Capital Management Ltd. MI	21,000	$26K	0.0%	N/A	0.017%
5/16/2023	Sabby Management LLC	65,714	$48K	0.0%	-67.9%	0.052%
5/15/2023	Two Sigma Advisers LP	60,800	$44K	0.0%	-33.6%	0.048%
5/12/2023	Renaissance Technologies LLC	936,070	$0.68M	0.0%	+10.8%	0.738%
5/12/2023	BlackRock Inc.	3,204,531	$2.32M	0.0%	-7.4%	2.527%
2/15/2023	Millennium Management LLC	563,567	$0.30M	0.0%	-15.9%	0.445%
2/14/2023	Two Sigma Investments LP	71,318	$38K	0.0%	-47.1%	0.056%
2/13/2023	Renaissance Technologies LLC	844,770	$0.45M	0.0%	-22.9%	0.667%
2/1/2023	Bank of Montreal Can	175,699	$0.11M	0.0%	N/A	0.139%
11/15/2022	Two Sigma Advisers LP	105,400	$88K	0.0%	-17.2%	0.083%
11/15/2022	Two Sigma Investments LP	134,886	$0.11M	0.0%	+78.1%	0.107%
11/15/2022	Vanguard Group Inc.	5,694,747	$4.75M	0.0%	-10.9%	4.497%
11/15/2022	BlackRock Inc.	3,534,875	$2.95M	0.0%	-1.5%	2.792%
11/14/2022	Renaissance Technologies LLC	1,095,710	$0.91M	0.0%	-44.9%	0.865%
11/14/2022	Ergoteles LLC	316,253	$0.26M	0.0%	-38.5%	0.250%
8/18/2022	Goldman Sachs Group Inc.	64,273	$70K	0.0%	-37.2%	0.051%
8/16/2022	Price T Rowe Associates Inc. MD	34,400	$37K	0.0%	-22.9%	0.027%
8/15/2022	AQR Capital Management LLC	79,335	$86K	0.0%	-52.5%	0.063%
8/15/2022	State Street Corp	480,995	$0.52M	0.0%	-78.5%	0.380%
8/15/2022	Laurion Capital Management LP	2,225,800	$2.43M	0.0%	N/A	1.758%
8/15/2022	Millennium Management LLC	1,534,502	$1.67M	0.0%	N/A	1.212%
8/13/2022	Renaissance Technologies LLC	1,989,995	$2.17M	0.0%	-5.3%	1.572%
8/12/2022	Northern Trust Corp	218,959	$0.24M	0.0%	-78.3%	0.173%
8/12/2022	Franklin Resources Inc.	48,040	$52K	0.0%	-32.6%	0.038%
8/11/2022	Bank of Montreal Can	309,600	$0.37M	0.0%	N/A	0.245%
6/7/2022	Bank of America Corp DE	47,856	$60K	0.0%	-62.6%	0.038%
5/18/2022	BNP Paribas Arbitrage SA	33,062	$41K	0.0%	-35.3%	0.026%
5/17/2022	First Republic Investment Management Inc.	25,167	$31K	0.0%	+79.8%	0.020%
5/16/2022	California State Teachers Retirement System	50,643	$63K	0.0%	-19.7%	0.040%
5/16/2022	Goldman Sachs Group Inc.	102,321	$0.13M	0.0%	-60.6%	0.081%
5/16/2022	State Street Corp	2,233,010	$2.79M	0.0%	+4.2%	1.763%
5/16/2022	UBS Group AG	36,089	$45K	0.0%	-50.4%	0.029%
5/13/2022	Renaissance Technologies LLC	2,100,492	$2.63M	0.0%	+79.5%	1.659%
5/13/2022	Northern Trust Corp	1,006,950	$1.26M	0.0%	-4.1%	0.795%
5/13/2022	Charles Schwab Investment Management Inc.	313,912	$0.39M	0.0%	+4.8%	0.248%
5/13/2022	Vanguard Group Inc.	6,892,416	$8.62M	0.0%	-1.1%	5.443%
5/12/2022	BlackRock Inc.	9,437,034	$11.80M	0.0%	-1.1%	7.453%
5/11/2022	JPMorgan Chase & Co.	54,960	$69K	0.0%	+27.0%	0.043%
5/11/2022	GSA Capital Partners LLP	66,223	$83K	0.0%	N/A	0.052%
4/18/2022	Spire Wealth Management	94,000	$0.12M	0.0%	+67.9%	0.074%
2/14/2022	ETF Managers Group LLC	38,452	$64K	0.0%	N/A	0.030%
2/11/2022	QCM Cayman Ltd.	22,301	$36K	0.2%	N/A	0.018%
2/10/2022	Qube Research & Technologies Ltd	287,989	$0.46M	0.0%	N/A	0.227%
2/9/2022	Principal Financial Group Inc.	26,254	$42K	0.0%	+144.2%	0.021%
2/9/2022	Alps Advisors Inc.	146,542	$0.23M	0.0%	N/A	0.116%
2/8/2022	ProShare Advisors LLC	25,560	$41K	0.0%	+70.5%	0.020%
2/8/2022	Northern Trust Corp	1,049,488	$1.68M	0.0%	-3.1%	0.829%
2/7/2022	SG Americas Securities LLC	36,270	$58K	0.0%	-55.9%	0.029%
2/1/2022	Qube Research & Technologies Ltd	287,989	$0.46M	0.0%	N/A	0.227%
11/16/2021	Metropolitan Life Insurance Co NY	15,468	$50K	0.0%	-54.1%	0.012%
11/15/2021	Franklin Resources Inc.	14,300	$47K	0.0%	N/A	0.011%
11/15/2021	Martingale Asset Management L P	28,381	$93K	0.0%	+28.5%	0.022%
11/12/2021	Geode Capital Management LLC	2,109,160	$6.88M	0.0%	+7.1%	1.666%
11/12/2021	Bank of Nova Scotia	152,115	$0.50M	0.0%	-56.4%	0.120%
11/12/2021	First Republic Investment Management Inc.	11,000	$36K	0.0%	N/A	0.009%
11/10/2021	Goldman Sachs Group Inc.	207,569	$0.68M	0.0%	+315.1%	0.164%
11/9/2021	Barclays PLC	47,810	$0.16M	0.0%	+107.2%	0.038%
11/9/2021	BlackRock Inc.	9,550,629	$31.14M	0.0%	+6.7%	7.543%
11/8/2021	State Board of Administration of Florida Retirement System	68,685	$0.22M	0.0%	+407.8%	0.054%
11/4/2021	Deutsche Bank AG	127,749	$0.42M	0.0%	+83.9%	0.101%
11/2/2021	New York State Common Retirement Fund	55,321	$0.18M	0.0%	-44.8%	0.044%
11/1/2021	SG Americas Securities LLC	82,160	$0.27M	0.0%	N/A	0.065%
10/29/2021	Commonwealth Equity Services LLC	28,442	$92K	0.0%	-14.8%	0.022%
10/27/2021	Newbridge Financial Services Group Inc.	32,000	$0.10M	0.1%	N/A	0.025%
10/22/2021	Spire Wealth Management	61,000	$0.20M	0.0%	+27.1%	0.048%
10/22/2021	Strs Ohio	14,200	$46K	0.0%	-47.6%	0.011%
10/19/2021	Kestra Advisory Services LLC	10,500	$34K	0.0%	N/A	0.008%
10/14/2021	Private Advisor Group LLC	11,205	$37K	0.0%	N/A	0.009%
9/17/2021	Virtu Financial LLC	18,624	$0.12M	0.0%	-93.2%	0.015%
9/3/2021	Parametric Portfolio Associates LLC	52,128	$0.33M	0.0%	N/A	0.041%
8/24/2021	Mariner LLC	114,860	$0.73M	0.0%	N/A	0.091%
8/17/2021	Invesco Ltd.	1,851,353	$11.70M	0.0%	N/A	1.464%
8/17/2021	Metropolitan Life Insurance Co NY	33,687	$0.21M	0.0%	N/A	0.027%
8/17/2021	Millennium Management LLC	1,666,911	$10.54M	0.0%	N/A	1.318%
8/17/2021	MetLife Investment Management LLC	44,000	$0.28M	0.0%	N/A	0.035%
8/17/2021	Price T Rowe Associates Inc. MD	24,844	$0.16M	0.0%	N/A	0.020%
8/16/2021	Squarepoint Ops LLC	188,259	$1.19M	0.0%	N/A	0.149%
8/16/2021	Amalgamated Bank	16,827	$0.11M	0.0%	N/A	0.013%
8/16/2021	Cubist Systematic Strategies LLC	5,257	$33K	0.0%	N/A	0.004%
8/16/2021	California State Teachers Retirement System	161,269	$1.02M	0.0%	N/A	0.128%
8/16/2021	Enlightenment Research LLC	73,100	$0.46M	0.6%	N/A	0.058%
8/16/2021	Charles Schwab Investment Management Inc.	293,958	$1.86M	0.0%	+976.5%	0.232%
8/16/2021	State Street Corp	2,032,668	$12.85M	0.0%	N/A	1.608%
8/16/2021	Nuveen Asset Management LLC	1,097,131	$6.93M	0.0%	N/A	0.868%
8/16/2021	Goldman Sachs Group Inc.	50,007	$0.32M	0.0%	-21.6%	0.040%
8/13/2021	Northern Trust Corp	1,123,852	$7.10M	0.0%	+671.6%	0.889%

Data available starting January 2016

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need in oncology. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201 for lung injury caused by cancer treatment. In addition, the company develops immunotherapy/chimeric antigen receptor therapy programs. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Today's Range

Now: $1.37

$1.33

$1.43

50 Day Range

MA: $1.39

$0.97

$2.10

52 Week Range

Now: $1.37

$0.59

$2.31

Volume

1,213,032 shs

Average Volume

2,982,947 shs

Market Capitalization

$171.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Atossa Therapeutics?: Atossa Therapeutics' top insider investors include:
Jonathan Finn (Director)
Learn More about top insider investors at Atossa Therapeutics.

The #1 Crypto for 2024

From InvestorPlace | Ad

Get His #1 Coin For 2024 FREE By Clicking Here

ATOS Insider Trading

Atossa Therapeutics Insider Trading History Chart

Atossa Therapeutics Share Price & Price History

Atossa Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Atossa Therapeutics (NASDAQ:ATOS)